Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 84833T103 since 12/18/2024, largest first.
| Filer | % of Class | Filed | ||
|---|---|---|---|---|
| GSK plc 13D/A | 16.4% |
3/28/2025
Event 3/27/2025
|
||
| Under 5%, checked the "5 percent or less" box, or amended by a later filing (1) | ||||
|
Anson Funds Management LP
13G/A
|
2.9% |
8/14/2025
Event 6/30/2025
|
||
| Anson Funds Management LP | 2.9% | |||
| Anson Management GP LLC | 2.9% | |||
| Tony Moore | 2.9% | |||
| Anson Advisors Inc. | 2.9% | |||
| Amin Nathoo | 2.9% | |||
| Moez Kassam | 2.9% | |||
| Period | Filings | Shares, Excl. Options | Value, Excl. Options |
|---|---|---|---|
| 2026 Q3 | 1 | 10.0 | $12.00 |
| 2026 Q2 | 66 | 21.5 M | $47.5 M |
| 2026 Q1 | 56 | 21.1 M | $49.3 M |
| 2025 Q4 | 58 | 21.1 M | $49.2 M |
| 2025 Q3 | 50 | 11.3 M | $21.3 M |
| 2025 Q2 | 48 | 11.1 M | $32.1 M |
| 2025 Q1 | 41 | 15.1 M | $10.9 M |
| 2024 Q4 | 55 | 16.1 M | $16.5 M |
| 2024 Q3 | 50 | 12.3 M | $16.5 M |
| 2024 Q2 | 53 | 13.9 M | $18.0 M |
| 2024 Q1 | 59 | 13.8 M | $23.7 M |
| 2023 Q4 | 53 | 13.8 M | $143 M |
| 2023 Q3 | 55 | 14.2 M | $17.2 M |
| 2023 Q2 | 59 | 14.4 M | $20.8 M |
| 2023 Q1 | 50 | 17.6 M | $25.5 M |
| 2022 Q4 | 64 | 14.3 M | $24.8 M |
| 2022 Q3 | 73 | 19.9 M | $39.7 M |
| 2022 Q2 | 82 | 21.0 M | $15.5 M |
| 2022 Q1 | 103 | 20.3 M | $180 M |
| 2021 Q4 | 93 | 19.9 M | $318 M |
| 2021 Q3 | 94 | 18.4 M | $338 M |
| 2021 Q2 | 96 | 17.5 M | $246 M |
| 2021 Q1 | 103 | 18.6 M | $273 M |
| 2020 Q4 | 102 | 19.4 M | $376 M |
| 2020 Q3 | 84 | 16.8 M | $187 M |
| 2020 Q2 | 84 | 11.8 M | $159 M |
| 2020 Q1 | 62 | 11.5 M | $93.2 M |
| 2019 Q4 | 63 | 10.9 M | $105 M |
| 2019 Q3 | 60 | 10.4 M | $110 M |
| 2019 Q2 | 62 | 10.6 M | $122 M |
| 2019 Q1 | 57 | 9.27 M | $119 M |
| 2018 Q4 | 54 | 9.19 M | $56.6 M |
| 2018 Q3 | 56 | 10.8 M | $113 M |
| 2018 Q2 | 45 | 8.13 M | $119 M |
| 2018 Q1 | 36 | 7.71 M | $110 M |
| 2017 Q4 | 37 | 7.76 M | $91.2 M |